GABRG2 rs4778138: Understanding Epilepsy Associations
The rs4778138 variant is a genetic marker located within the GABRG2 gene, which provides instructions for building a critical component of the brain's inhibitory signaling system. Research has identified associations between variations in this gene and an increased susceptibility to various forms of epilepsy.
What each genotype means
Typical genetic risk profile
This genotype represents the most common form of this variant found in the general population. While the GABRG2 gene is known to play a critical role in brain signaling and epilepsy susceptibility, this specific common variant does not independently indicate a high risk for developing epilepsy. Please consult with a healthcare professional if you have personal or family concerns regarding neurological health.
This is the most frequent genotype observed across most global populations.
Typical genetic risk profile
Carrying one copy of the minor allele for this variant is common and is not considered a primary driver of epilepsy on its own. Research into GABRG2 focuses heavily on rare, high-impact mutations, whereas common variants like this one generally have a minimal individual effect on overall seizure risk. Discuss any specific health concerns with your physician.
This genotype is found in a significant portion of the population, varying by ancestral background.
Typical genetic risk profile
This genotype is a common variation in the GABRG2 gene and is not typically associated with a significant increase in epilepsy risk. While GABRG2 is an important gene for GABA receptor function, common variants like this one are generally considered to have a low impact on clinical outcomes. Always speak with a qualified clinician if you are evaluating your personal risk for neurological conditions.
This genotype is present at varying frequencies across different global populations, representing a standard genetic variation.
What is rs4778138 and Where is it Located?
The rs4778138 variant is a single nucleotide polymorphism (SNP) situated within the GABRG2 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. The GABRG2 gene is located on chromosome 5 and is responsible for encoding the gamma-2 subunit of the GABA-A receptor. This receptor is a ligand-gated ion channel that plays a fundamental role in the central nervous system by mediating inhibitory neurotransmission. By allowing chloride ions to flow into neurons, the GABA-A receptor helps to dampen neuronal excitability, effectively acting as a 'brake' for the brain's electrical activity. Because rs4778138 is located within this gene, researchers study it to determine if specific DNA changes at this site influence the structure or expression of the receptor, potentially altering how the brain regulates electrical signals.
The Role of GABRG2 in Brain Function
The GABRG2 gene is essential for the proper assembly and function of GABA-A receptors, which are the primary inhibitory receptors in the human brain. These receptors are pentameric, meaning they are composed of five subunits, and the gamma-2 subunit is crucial for the receptor's localization at the synapse and its sensitivity to benzodiazepines. When the GABRG2 gene functions correctly, it ensures that the brain can effectively inhibit excessive neuronal firing. However, when the gene is altered, the resulting receptors may be dysfunctional, leading to an imbalance between excitation and inhibition in the brain. This imbalance is a hallmark of epilepsy, a condition characterized by recurrent, unprovoked seizures. While many variants in GABRG2 are rare and have clear, severe effects, common variants like rs4778138 are studied to see if they contribute to a broader, more subtle predisposition to seizure disorders across the general population.
Research Associations and Evidence Strength
The association between GABRG2 and epilepsy is well-documented in scientific literature, with variants in this gene linked to a spectrum of conditions ranging from simple febrile seizures to severe developmental and epileptic encephalopathies. The evidence for rs4778138 specifically is categorized as moderate, meaning that while statistical associations have been observed in various studies, the variant does not act as a single, definitive cause of epilepsy. Instead, it is often viewed as a potential risk factor that may interact with other genetic and environmental influences. It is important to note that the presence of a risk-associated variant does not guarantee the development of a condition. Many individuals carry such variants without ever experiencing seizures, as the penetrance of these genetic markers is often low and heavily influenced by an individual's overall polygenic background and other external factors.
Population Frequency and Genetic Diversity
The rs4778138 variant is considered a common SNP, meaning it is found at a relatively high frequency across diverse human populations. Genetic databases indicate that the alleles for this variant are widely distributed, though the exact frequency can vary significantly depending on ancestral background. Because it is common, it is present in many healthy individuals who do not have epilepsy, which underscores the complexity of genetic risk. In the context of complex diseases like epilepsy, common variants often have small individual effect sizes. This means that while a variant might be statistically associated with a slightly higher risk of a condition, it is rarely the sole driver of the disease. Understanding the frequency of this variant helps researchers contextualize its role within the broader human genome and highlights the importance of considering the entire genetic landscape rather than focusing on a single marker.
Interpreting Your Genetic Information
Information regarding genetic variants like rs4778138 is intended for educational purposes and should not be used for medical diagnosis or to make personal health decisions. Genetic associations are based on population-level statistics and cannot predict an individual's health outcome with certainty. If you have concerns about epilepsy, seizure history, or your family's health, it is essential to consult with a qualified healthcare professional, such as a neurologist or a genetic counselor. They can provide context based on your personal medical history and clinical symptoms, which are far more predictive of health than any single genetic marker. Never change or stop any prescribed medication based on genetic test results without first discussing it with your clinician or pharmacist. Genetic testing is a tool for understanding biological predispositions, but it is only one piece of a much larger clinical puzzle.
How common is this variant?
The rs4778138 variant is common across global populations, with its specific allele frequencies varying by ancestry as documented in large-scale genomic databases.
Frequently asked questions
Does having the rs4778138 variant mean I will develop epilepsy?
No. Having a specific genotype for this variant does not mean you will develop epilepsy. Most people with this variant do not have any seizure disorders, as genetic risk is complex and influenced by many other factors.
Is rs4778138 a diagnostic test for epilepsy?
No, this variant is not used as a diagnostic test. Epilepsy is a clinical diagnosis made by a doctor based on symptoms, medical history, and diagnostic tests like an EEG or MRI, not by a single genetic marker.
Can I use this information to change my medication?
You should never change or stop any medication based on genetic information. Always discuss your medications and any concerns about genetic predispositions with your doctor or pharmacist.
Why is the evidence for this variant considered moderate?
The evidence is considered moderate because while studies show a statistical association with epilepsy, the variant's individual effect is small. It is likely one of many factors that contribute to risk rather than a direct cause.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4778138?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GABRG2
This variant in the GABRG2 gene is associated with variations in response to certain anticonvulsant medications and epilepsy susceptibility.
Variant in GABRG2, a gene where mutations can alter GABA-A receptor function and influence seizure thresholds.
Mutations in GABRG2 are linked to a spectrum of epilepsy ranging from simple febrile seizures to severe developmental and epileptic encephalopathies.
This variant is located in the GABRG2 gene, which encodes the gamma-2 subunit of the GABA-A receptor; variants in this gene are associated with a spectrum of epilepsy syndromes.
A common variant in GABRG2, a gene encoding a GABA-A receptor subunit linked to various epilepsy phenotypes including febrile seizures and GEFS+.
Linked to GABA-A receptor subunit dysfunction, a known mechanism for inherited epilepsy syndromes.